Cytek Biosciences, Inc. ( CTKB) - Key Metrics
CTKB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.48 | -$0.34 | -$0.01 | -$0.01 |
| 2025Q3 | $0.41 | -$0.04 | -$0.03 | -$0.04 |
| 2025Q2 | $0.36 | -$0.04 | $0 | -$0.01 |
| 2025Q1 | $0.32 | -$0.09 | $0 | -$0.01 |
CTKB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.67 |
| 2025Q3 | ? | -20.20 |
| 2025Q2 | ? | -19.33 |
| 2025Q1 | ? | -11.28 |
CTKB
Price: $4.33
52 week price:
Earnings Per Share: -0.58 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 1.0 million
Market Capitalization: 521.7 million